Abstract: Described are passenger support assemblies for a passenger seat, including an expandable inner frame that attaches the passenger support assembly with a seat frame and an expansion mechanism that allows the expandable inner frame to change in width, and an outer frame that includes two side frame elements connected with the expandable inner frame and extending beyond the expandable inner frame, the outer frame configured to change in width in response to a change in width of the expandable inner frame. A diaphragm can held in tension by the two side frame elements of the outer frame to define a seating surface.

Abstract: A child resistant lip product material dispenser comprises a body having a first opening at a first end and external threads disposed on an external surface of the body proximate the first end. A rotary module has first internal threads configured to engage with the external threads, and a lid is disposed on the rotary module. A lip product material is at least partially disposed within the body. The rotary module further comprises a first plurality of spaced teeth arranged in a circular pattern on a surface of the rotary module facing the lid, and the lid comprises a second plurality of spaced teeth arranged in a circular pattern on a surface of the lid facing the rotary module, wherein the first and second pluralities of spaced teeth are configured to mesh together.

Abstract: Systems and methods associated with performing checkpoint and build processing associated with a continuous integration/continuous deployment (CI/CD) pipeline. In one embodiment, an exemplary method may include identifying an outside dependence for a new cloud process to be integrated into a CI/CD build of a CI/CD pipeline, determining on a periodic or ongoing basis whether a current status of the outside dependence identifies it as incomplete such that a new cloud process would not perform as desired until the dependence is complete, preventing the new cloud process from being integrated into the CI/CD build until the current status indicates that the outside dependence is complete, and integrating the new cloud process into the CI/CD build when the current status indicates that the outside dependence is complete.

Abstract: Described are passenger support assemblies for a passenger seat, including an expandable inner frame that attaches the passenger support assembly with a seat frame and an expansion mechanism that allows the expandable inner frame to change in width, and an outer frame that includes two side frame elements connected with the expandable inner frame and extending beyond the expandable inner frame, the outer frame configured to change in width in response to a change in width of the expandable inner frame. A diaphragm can held in tension by the two side frame elements of the outer frame to define a seating surface.

Abstract: The present invention relates to compounds useful as inhibitors of DNA-PK. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.

Abstract: The present invention relates to compounds useful as inhibitors of DNA-PK. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.

Abstract: The present invention relates to compounds useful as inhibitors of DNA-PK. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.

Abstract: The present invention relates to compounds useful as inhibitors of DNA-PK. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.

Abstract: The present invention relates to compounds useful as inhibitors of DNA-PK. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.

Abstract: The present invention relates to a compound useful as a selective inhibitor of PI3K?. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.

Abstract: A passenger seat arrangement is provided for a single-aisle vehicle, such as a narrow-body aircraft. In some examples, the passenger seat includes a passenger seat having a seat plane. The passenger seat is positioned such that the seat plane is at a non-square and non-zero acute angle relative to a plane of the aisle. The passenger seat is a non-lie flat seat movable between an upright position and a neutral position. A seat back of the passenger seat is at a non-zero angle relative to a seat base of the passenger seat in both the upright position and the neutral position.

Abstract: The present invention relates to compounds useful as inhibitors of DNA-PK. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.

Abstract: A passenger seat (100) that includes at least one back rest frame (191-194) with at least one through-hole, at least one lateral structural member (101,102) that is perpendicular to the at least one back rest frame (191-194) and is disposed in the at least one through-hole, and at least one floor attachment frame (195,196) with at least one through-hole that is coaxial with the at least one through-hole of the at least one back rest frame (191-194). Each lateral structural member include an internal composite tube (101,102) that extends a full lateral width of the passenger seat and a plurality of outer tubes (151-162) disposed on an outer surface of the internal composite tube.

Abstract: The present invention relates to compounds useful as inhibitors of DNA-PK. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.

Abstract: The present invention relates to compounds useful as inhibitors of DNA-PK. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.

Abstract: The present invention relates to compounds useful as inhibitors of DNA-PK. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.

Abstract: The present invention relates to compounds useful as inhibitors of DNA-PK. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.

Abstract: The present invention relates to compounds useful as inhibitors of DNA-PK. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.

Abstract: The present invention relates to compounds useful as inhibitors of DNA-PK. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.

Abstract: A hydrogen and oxygen (HHO) gas on-demand electrolysis fuel cell system for use with internal combustion engines is disclosed. This hydrogen on-demand (HOD) system integrates with the engine control module (ECM) or other control system that regulates the operation of an internal combustion engine in order to supply HHO to the engine and improve the engine's overall fuel efficiency. This system includes an electrolyte fluid reservoir outfitted with level, pressure and temperature sensors; a pump and heat exchanger; a uniquely-configured electrolyzer; and a filter. The combined engine and HOD system is controlled and regulated by an electronic control system (ECS) and a combustion control module (CCM). The CCM is installed on the engine such that it actively intercepts the electronic signals from the engine manufacturer's ECM to continuously coordinate the functions and operations of the HOD system and the engine.